Toll-like Receptors and Lupus Nephritis

被引:22
作者
Conti, Fabrizio [1 ]
Spinelli, Francesca Romana [1 ]
Alessandri, Cristiano [1 ]
Valesini, Guido [1 ]
机构
[1] Sapienza Univ Roma, Dipartimento Clin & Terapia Med, Sezione Reumatol, I-00161 Rome, Italy
关键词
Toll-like receptors; Systemic lupus erythematosus; Lupus nephritis; Innate immunity; IMMUNE-COMPLEX GLOMERULONEPHRITIS; B-CELLS; CPG-DNA; EXPRESSION; INJURY; TOLL-LIKE-RECEPTOR-7; ACTIVATION; AUTOANTIBODIES; AUTOIMMUNITY; SURVIVAL;
D O I
10.1007/s12016-010-8208-0
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
A variety of immune mechanisms, both humoral and cellular, are involved in the onset and amplification of the inflammatory response in lupus nephritis (LN). Accumulating evidence substantiates the view that innate immunity pathways may also amplify inflammatory reactions within the kidneys. Toll-like receptors (TLRs) are essential modulators of the innate immune response thanks to their ability to rocognize conserved molecular patterns that are microbe specific and other danger signals. Their recognition of endogenous molecules released from injured cells may also contribute to renal inflammation. Studies conducted in vivo and in vitro provide experimental evidence for the functional role of TLRs in LN. Intriguingly, these data suggest that pharmacological TLR signal suppression could be a useful approach to the treatment of systemic lupus erythematosus.
引用
收藏
页码:192 / 198
页数:7
相关论文
共 49 条
[1]   Activation of toll-like receptor-9 induces progression of renal disease in MRL-Fas(lpr) mice [J].
Anders, HJ ;
Vielhauer, V ;
Eis, V ;
Linde, Y ;
Kretzler, M ;
de Lema, GP ;
Strutz, F ;
Bauer, S ;
Rutz, M ;
Wagner, H ;
Gröne, HJ ;
Schlbndorff, D .
FASEB JOURNAL, 2004, 18 (01) :534-+
[2]   Bacterial CpG-DNA aggravates immune complex glomerulonephritis:: Role of TLR9-mediated expression of chemokines and chemokine receptors [J].
Anders, HJ ;
Banas, B ;
Linde, Y ;
Weller, L ;
Cohen, CD ;
Kretzler, M ;
Martin, S ;
Vielhauer, V ;
Schlöndorff, D ;
Gröne, HJ .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 (02) :317-326
[3]   NUMBER OF CPG ISLANDS AND GENES IN HUMAN AND MOUSE [J].
ANTEQUERA, F ;
BIRD, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (24) :11995-11999
[4]   Nucleic acids of mammalian origin can act as endogenous ligands for toll-like receptors and may promote systemic lupus erythematosus [J].
Barrat, FJ ;
Meeker, T ;
Gregorio, J ;
Chan, JH ;
Uematsu, S ;
Akira, S ;
Chang, B ;
Duramad, O ;
Coffman, RL .
JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 202 (08) :1131-1139
[5]   Involvement of renal tubular toll-like receptor 9 in the development of tubulointerstitial injury in systemic lupus [J].
Benigni, Ariela ;
Caroli, Cristina ;
Longaretti, Lorena ;
Gagliardini, Elena ;
Zoja, Carla ;
Galbusera, Miriam ;
Moioli, Daniela ;
Romagnani, Paola ;
Tincani, Angela ;
Andreoli, Laura ;
Remuzzi, Giuseppe .
ARTHRITIS AND RHEUMATISM, 2007, 56 (05) :1569-1578
[6]   Urine proteomics for the early diagnosis of acute glomerulonephritis: Has the time come? [J].
Boumpas, Dimitrios T. ;
Kuroiwa, Takashi .
ARTHRITIS AND RHEUMATISM, 2007, 56 (03) :705-709
[7]   Recent insights into the structure of Toll-like receptors and post-translational modifications of their associated signalling proteins [J].
Carpenter, Susan ;
O'Neill, Luke A. J. .
BIOCHEMICAL JOURNAL, 2009, 422 :1-10
[8]   Toll-like receptor signaling: a critical modulator of cell survival and ischemic injury in the heart [J].
Chao, Wei .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2009, 296 (01) :H1-H12
[9]   Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus [J].
Christensen, Sean R. ;
Shupe, Jonathan ;
Nickerson, Kevin ;
Kashgarian, Michael ;
Flavell, Richard A. ;
Shlomchik, Mark J. .
IMMUNITY, 2006, 25 (03) :417-428
[10]   Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus [J].
Christensen, SR ;
Kashgarian, M ;
Alexopoulou, L ;
Flavell, RA ;
Akira, S ;
Shlomchik, MJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 202 (02) :321-331